Novartis releases new data on benefits of Kesimpta in relapsing multiple sclerosis
Novartis has released new data from two Kesimpta (ofatumumab) studies in relapsing multiple sclerosis (RMS) that will be presented…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.